1 |
Atlante, A., Calissano, P, Bobba, A., Giannattasio, S.. Marra, E. and Passarella, S. (2001). Glutamate neurotoxicity, oxidative stress and mitochondria. FEBS Lelt. 497, 1-5
DOI
ScienceOn
|
2 |
Bernardi, P. (1996). The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1275, 5-9
DOI
ScienceOn
|
3 |
Birkrnayer, W., Knoll, J., Riederer, P, Youdirn, M. B., Hars, V. and Marton, J. (1985). Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterrn study. J. Neural. Transm. 64, 113-127
DOI
|
4 |
Cassarino, D. S., Parks, J. K., Parker, W. D. Jr. and Bennett, J. P. Jr. (1999). The Parkinsonian neurotoxin MPP opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acra 1453, 49-62
DOI
ScienceOn
|
5 |
Chakraborati. T., Das, S., Mondal, M.. Roychoudhury, S. and Chakraborti, S. (1999). Oxidant, mitochondria and calcium: an overview. Cell Signal. 11, 77-85
DOI
ScienceOn
|
6 |
Chandra, J., Sarnali, A. and Orrenius, S. (2000). Triggering and modulation of apoptosis by oxidative stress. Free Radic. Bioi. Med. 29, 323-333
DOI
ScienceOn
|
7 |
Gearhart, D. A., Toole, P. F. and Beach, J. W. (2002). Identification of brain proteins that interact with 2-methylnorharman, An analog of the parkinsonian-inducing toxin, MPP. Neurosci. Res. 44, 255-265
DOI
ScienceOn
|
8 |
Halliwell, B. and Guueridge, J. M. C (1999). Detection of free radicals and other reactive species: trapping and fingerprinting. In Free radicals in biology and medicine. 3rd Ed, (B. Halliwell and J. M. C Guueridge, Eds.), pp.351-429. Oxford University Press, New York, USA
|
9 |
Jacobsson, S. O. and Fowler, C. J. (1999). Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of NMDA antagonists, antioxidants and MAO inhibitors. Neurochem. Int. 34, 49-62
DOI
ScienceOn
|
10 |
Jurrna, O. P., Hom, D. G. and Andersen, J. K. (1997). Decreased glutathione results in calcium-mediated cell death in PC 12. Free Radic. Bioi. Med. 23, 1055-1066
DOI
ScienceOn
|
11 |
Matsubara, K., Gonda, T, Sawada, H., Uezono, T, Kobayashi, Y, Kawamura, T, Ohtaki, K., Kimura, K. and Akaike, A. (1998). Endogenously occurring -carboline induces Parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease. J. Neurochem. 70, 727-735
DOI
ScienceOn
|
12 |
Kim, D. H., Jang, Y Y, Han, E. S. and Lee, C. S. (2001). Protective effect of harmaline and harmalol against dopamine- and 6hydroxydoparnine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC 12 cells. Eur: J. Neurosci. 13, 1861-1872
DOI
ScienceOn
|
13 |
Amarante-Mendes, G. P, Kim, C. N., Liu, L., Huang, Y., Perkins, C. L., Greeen, D. R. and Bhalla, K. (1998). Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockade of mitochondrial release of cytochrome c and activation of caspase-S, Blood 91, 1700-1705
|
14 |
Aruoma, O. I. (1994). Deoxyribose assay for detecting hydroxyl radicals. In Methods Enrymol. (L. Packer, Ed.), Vol. 233. pp.57-66. Academic Press, San Diego, USA
|
15 |
Mosmann, T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Method, 65, 55-63
DOI
ScienceOn
|
16 |
O'Hearn, E. and Molliver, M. E. (1993). Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55, 303-310
DOI
ScienceOn
|
17 |
Olanow, C. W. and Tatton, W G. (1999). Etiology and pathogenesis of'Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144
|
18 |
Pereira, C. F. and Oliveira, C. R. (2000). Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca homeostasis. Neurosci. Res. 37, 227-236.
DOI
ScienceOn
|
19 |
Du, Y., Dodel, R. C.. Bales, K. R., Jemmerson. R., HamiionByrd, E. and Paul, S. M. (1997). Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J. Neurochem. 69, 1382-1388
DOI
ScienceOn
|
20 |
Cobuzzi, R. J. Jr.. Ncafsey, E. J. and Collins, M. A. (1994). Differential cytotoxicities of N-methyl--carbolinium analogue, of MPP in PC12 cells: insights into potential neurotoxicants in Parkinson's disease. J. Neurochem. 62, 1503-1510
DOI
ScienceOn
|
21 |
Fu, W., Luo, H., Parthasarathy, S. and Mattson, M. P. (1998). Catecholamines potentiate amyloid --peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis. 5, 229-243
DOI
ScienceOn
|
22 |
Zeevalk, C. D., Bernard, L P, Albers, D. 5., Mirochnitchenko, O., Nicklas, W. land Sonsalla, P. K. (1997). Energy stressinduced dopamine loss in glutathione peroxidase-overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures. J. Neurochem. 68, 426-429
DOI
ScienceOn
|
23 |
Lai, C-T and Yu, PH. (1997). Dopamine- and L--3,4-dihydroxyphcnylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem. Pharmacal. 53, 363-372
DOI
ScienceOn
|
24 |
Tan, S., Sagara, Y., Liu, Y., Maher, P. and Schubert, D. (1998). The regulation of reactive oxygen species production during programmed cell death. J. Cell Biol. 141, 1423-1432
DOI
ScienceOn
|
25 |
Lee, C S., Han, E. S., Jang, Y. Y., Han, J. H., Ha, H. W. and Kim, D. E. (2000). Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC 12 Cells. J. Neurochem. 75, 521-531
DOI
ScienceOn
|
26 |
Lee, C. S., Han, J. H, Jang, Y. Y., Song, J. H. and Han, E. S. (2002). Differential effect of catecholamines and MPP on membrane permeability in brain mitochondria and cell viability in PCI2 cells. Neurochem. Int. 40, 361-369
DOI
ScienceOn
|
27 |
Lotharius, J., Dugan, L. L. and O'Malley, K. L. (1999). Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19, 1284-1293
|
28 |
van Klaveren, R. J., Hoet, P. H., Pype, J. L., Demedts, M. and Nemery, B. (1997). Increase in garnma-glutamyltransferase by glutathione depletion in rat type n pneumocytes, Free Radic. Biol. Med. 22, 525-534
DOI
ScienceOn
|
29 |
Tatton, W. G, and Chalmers-Redman, R. M. E. (1996). Modulation of gene expression rather than monoamine oxidase inhibition. Neurology 47(Suppi. 3), S171-S183
DOI
|
30 |
Tatton, W. G., Chalmers-Redman, R. M. E., Ju, W. J. H., Mammen, M.. Carlile, G. W, Pong, A. W. and Tatton. N. A. (2002). Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NCF-differentiated PC-12 cells. J. Phannacol. Exp. Ther. 301, 753-764
DOI
ScienceOn
|
31 |
Wu, R. M., Chen, R. C. and Chiueh, C. C. (2000). Effect of MAO-B inhibitor, on MPP toxicity in Vivo. Ann, N. Y. Acad. Sci. 899,255-261
|